Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea
Antimicrobial Agents and Chemotherapy, ISSN: 1098-6596, Vol: 58, Issue: 11, Page: 6958-6961
2014
- 10Citations
- 35Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes9
- CrossRef7
- Policy Citations1
- 1
- Captures35
- Readers35
- 35
Article Description
Intermittent preventive treatment of infants (IPTi) reduces early childhood malaria-related morbidity. While genotypic drug resistance markers have proven useful in predicting the efficacy of antimalarial drugs in case management, there are few equivalent data relating to their protective efficacy when used as IPTi. The present data from an IPTi trial in Papua New Guinea demonstrate how these markers can predict protective efficacy of IPTi for both Plasmodium falciparum and Plasmodium vivax.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84908432772&origin=inward; http://dx.doi.org/10.1128/aac.03323-14; http://www.ncbi.nlm.nih.gov/pubmed/25155586; http://aac.asm.org/lookup/doi/10.1128/AAC.03323-14; https://syndication.highwire.org/content/doi/10.1128/AAC.03323-14; https://journals.asm.org/doi/10.1128/AAC.03323-14; https://dx.doi.org/10.1128/aac.03323-14; https://aac.asm.org/content/58/11/6958; https://aac.asm.org/content/58/11/6958.abstract; https://aac.asm.org/content/aac/58/11/6958.full.pdf; http://aac.asm.org/content/58/11/6958; https://aac.asm.org/content/58/11/6958.full.pdf; https://research-repository.uwa.edu.au/en/publications/762eeec8-1ec6-4d42-b3ea-077e3ac56cef; https://research-repository.uwa.edu.au/en/publications/plasmodium-falciparum-and-plasmodium-vivax-genotypes-and-efficacy; https://research-repository.uwa.edu.au/en/publications/plasmodium-falciparum-and-plasmodium-vivax-genotypes-and-efficacy-of-intermittent-preventive-treatment-in-papua-new-guinea(762eeec8-1ec6-4d42-b3ea-077e3ac56cef).html; https://journals.asm.org/doi/abs/10.1128/AAC.03323-14; http://aac.asm.org/cgi/doi/10.1128/AAC.03323-14; http://research-repository.uwa.edu.au/en/publications/plasmodium-falciparum-and-plasmodium-vivax-genotypes-and-efficacy-of-intermittent-preventive-treatment-in-papua-new-guinea(762eeec8-1ec6-4d42-b3ea-077e3ac56cef).html
American Society for Microbiology
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know